Carbohydrate / דלקת

Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to

Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to

Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to

Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to Lactobacillus secreted proteins, carbohydrates and lipids and other anaerobic bacterial strains known to exert effects similar to Lactobacillus strains and their use in the prevention and treatment of

Carbohydrate-based anti-inflammatory agents

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

FIELD OF THE INVENTION This invention relates generally to determining the presence of and relieving the effects of inflammation. More specifically, this invention relates to carbohydrate ligands which bind to endothelial leukocyte adhesion molecule-1 (hereinafter ELAM-1) and to compositions

Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

This application is a 371 of PCT/GB93/00649, filed Mar. 29, 1993. The present invention relates, broadly, to the treatment of prevention of inflammation, whether caused by bacteria, viruses and/or other infective agents, opportunistic infections (which may be consequent on an immunodepressed state,

Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

The present invention relates, broadly to the treatment or prevention of inflammation, whether caused by bacteria, viruses and/or other infective agents, opportunistic infections (which may be consequent on an immunodepressed state, for example resulting from cancer or therapy, particularly

Anti-flammatory carbohydrate binding-peptides

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention is directed to methods for inhibiting immune responses or cellular interactions in mammals by the administration thereto of one or more lectin derived carbohydrate binding peptides. In particular, this invention is directed to

Inhibition of cell adhesion protein-carbohydrate interactions

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION This invention relates to therapeutic interference with interactions between cell adhesion proteins and their carbohydrate ligands. ELAM-1 is an integral membrane adhesion protein. It possesses an extracellular domain including an N-terminal lectin-related segment, an

Inhibition of cell adhesion protein-carbohydrate interactions

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION This invention relates to therapeutic interference with interactions between cell adhesion proteins and their carbohydrate ligands. ELAM-1 is an integral membrane adhesion protein. It possesses an extracellular domain including an N-terminal lectin-related segment, an

Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION This invention relates to therapeutic interference with interactions between cell adhesion proteins and their carbohydrate ligands. ELAM-1 is an integral membrane adhesion protein. It possesses an extracellular domain including an N-terminal lectin-related segment, an

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND AND FIELD OF THE INVENTION Complex carbohydrates, for purposes of this invention are defined as any polymer comprising more than two sugar moieties and would thus include such classes of compounds as polysaccharides and oligosaccharides. Polysaccharides include glycosaminoglycans and

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND AND FIELD OF THE INVENTION Complex carbohydrates, for purposes of this invention are defined as any polymer comprising more than two sugar moieties and would thus include such classes of and oliosaccharides. Polysaccharides include glycosaminoglycans and mannans whereas oligosaccharides

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND AND FIELD OF THE INVENTION The invention relates to a method of preventing and treating diseases and conditions of mammals associated with the adhesion, metastatic and coronary cascades comprising applying a composition of complex carbohydrates and essential oils topically, orally or

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND AND FIELD OF THE INVENTION The invention relates to a method of preventing and treating diseases and conditions of mammals associated with the adhesion, metastatic and coronary cascades comprising applying a composition of complex carbohydrates and essential oils topically, orally or

carbohydrate/דלקת

Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides

Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides

Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides

Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids

Carbohydrate-based anti-inflammatory agents

Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease

Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis

Anti-flammatory carbohydrate binding-peptides

Inhibition of cell adhesion protein-carbohydrate interactions

Inhibition of cell adhesion protein-carbohydrate interactions

Nucleic acid encoding an antibody that inhibits cell adhesion protein-carbohydrate interactions

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע